nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—HTR2C—schizophrenia	0.211	0.363	CbGaD
Sorafenib—CYP1A2—schizophrenia	0.16	0.274	CbGaD
Sorafenib—CYP2D6—schizophrenia	0.123	0.212	CbGaD
Sorafenib—ABCB1—schizophrenia	0.0879	0.151	CbGaD
Sorafenib—MKNK1—telencephalon—schizophrenia	0.000785	0.00462	CbGeAlD
Sorafenib—AURKC—nervous system—schizophrenia	0.000781	0.0046	CbGeAlD
Sorafenib—RALBP1—forebrain—schizophrenia	0.00078	0.00459	CbGeAlD
Sorafenib—MAPK11—central nervous system—schizophrenia	0.000777	0.00457	CbGeAlD
Sorafenib—EPHA6—endocrine gland—schizophrenia	0.000773	0.00455	CbGeAlD
Sorafenib—CDK7—central nervous system—schizophrenia	0.000764	0.0045	CbGeAlD
Sorafenib—MAPK11—cerebellum—schizophrenia	0.000759	0.00447	CbGeAlD
Sorafenib—AURKC—central nervous system—schizophrenia	0.000752	0.00443	CbGeAlD
Sorafenib—CDK7—cerebellum—schizophrenia	0.000747	0.00439	CbGeAlD
Sorafenib—CYP3A4—urine—schizophrenia	0.000744	0.00438	CbGeAlD
Sorafenib—TAOK2—cerebellum—schizophrenia	0.000741	0.00436	CbGeAlD
Sorafenib—BRAF—blood—schizophrenia	0.000741	0.00436	CbGeAlD
Sorafenib—RAF1—forebrain—schizophrenia	0.000738	0.00434	CbGeAlD
Sorafenib—EPHB6—forebrain—schizophrenia	0.000734	0.00432	CbGeAlD
Sorafenib—ZAK—endocrine gland—schizophrenia	0.000733	0.00431	CbGeAlD
Sorafenib—CYP2D6—urine—schizophrenia	0.000732	0.00431	CbGeAlD
Sorafenib—BRAF—midbrain—schizophrenia	0.000731	0.00431	CbGeAlD
Sorafenib—EPHA6—nervous system—schizophrenia	0.000723	0.00426	CbGeAlD
Sorafenib—RALBP1—telencephalon—schizophrenia	0.000718	0.00422	CbGeAlD
Sorafenib—HIPK3—endocrine gland—schizophrenia	0.000717	0.00422	CbGeAlD
Sorafenib—EPHX2—blood—schizophrenia	0.000708	0.00417	CbGeAlD
Sorafenib—FLT3—blood—schizophrenia	0.000703	0.00414	CbGeAlD
Sorafenib—HIPK4—brain—schizophrenia	0.0007	0.00412	CbGeAlD
Sorafenib—EPHA6—central nervous system—schizophrenia	0.000696	0.0041	CbGeAlD
Sorafenib—PDGFRA—forebrain—schizophrenia	0.000696	0.00409	CbGeAlD
Sorafenib—ZAK—nervous system—schizophrenia	0.000686	0.00404	CbGeAlD
Sorafenib—FLT1—telencephalon—schizophrenia	0.000683	0.00402	CbGeAlD
Sorafenib—RAF1—telencephalon—schizophrenia	0.000679	0.00399	CbGeAlD
Sorafenib—EPHB6—telencephalon—schizophrenia	0.000675	0.00397	CbGeAlD
Sorafenib—MKNK2—gonad—schizophrenia	0.000663	0.0039	CbGeAlD
Sorafenib—ZAK—central nervous system—schizophrenia	0.00066	0.00389	CbGeAlD
Sorafenib—MAP3K19—nervous system—schizophrenia	0.000657	0.00387	CbGeAlD
Sorafenib—CYP2C19—blood plasma—schizophrenia	0.000657	0.00386	CbGeAlD
Sorafenib—MKNK1—gonad—schizophrenia	0.000655	0.00385	CbGeAlD
Sorafenib—ZAK—cerebellum—schizophrenia	0.000645	0.0038	CbGeAlD
Sorafenib—PDGFRA—telencephalon—schizophrenia	0.00064	0.00376	CbGeAlD
Sorafenib—FLT4—blood—schizophrenia	0.000638	0.00376	CbGeAlD
Sorafenib—MAP3K19—central nervous system—schizophrenia	0.000633	0.00373	CbGeAlD
Sorafenib—HIPK3—cerebellum—schizophrenia	0.000632	0.00372	CbGeAlD
Sorafenib—KDR—forebrain—schizophrenia	0.000628	0.00369	CbGeAlD
Sorafenib—TIE1—nervous system—schizophrenia	0.000627	0.00369	CbGeAlD
Sorafenib—FGFR1—midbrain—schizophrenia	0.000622	0.00366	CbGeAlD
Sorafenib—Regorafenib—ABCB1—schizophrenia	0.000619	0.558	CrCbGaD
Sorafenib—MAPK11—brain—schizophrenia	0.000616	0.00363	CbGeAlD
Sorafenib—CSF1R—forebrain—schizophrenia	0.000612	0.0036	CbGeAlD
Sorafenib—FLT3—endocrine gland—schizophrenia	0.00061	0.00359	CbGeAlD
Sorafenib—CDK7—brain—schizophrenia	0.000607	0.00357	CbGeAlD
Sorafenib—TIE1—central nervous system—schizophrenia	0.000604	0.00355	CbGeAlD
Sorafenib—TAOK2—brain—schizophrenia	0.000602	0.00354	CbGeAlD
Sorafenib—AURKC—brain—schizophrenia	0.000597	0.00351	CbGeAlD
Sorafenib—MAP3K7—blood—schizophrenia	0.000596	0.00351	CbGeAlD
Sorafenib—TIE1—cerebellum—schizophrenia	0.00059	0.00347	CbGeAlD
Sorafenib—MAP3K7—midbrain—schizophrenia	0.000589	0.00347	CbGeAlD
Sorafenib—MKNK2—blood—schizophrenia	0.000578	0.0034	CbGeAlD
Sorafenib—MAP2K5—telencephalon—schizophrenia	0.000577	0.0034	CbGeAlD
Sorafenib—CYP2C8—blood plasma—schizophrenia	0.000573	0.00337	CbGeAlD
Sorafenib—MKNK2—midbrain—schizophrenia	0.000571	0.00336	CbGeAlD
Sorafenib—MKNK1—blood—schizophrenia	0.000571	0.00336	CbGeAlD
Sorafenib—FLT1—gonad—schizophrenia	0.00057	0.00335	CbGeAlD
Sorafenib—RAF1—gonad—schizophrenia	0.000566	0.00333	CbGeAlD
Sorafenib—BRAF—cerebellum—schizophrenia	0.000566	0.00333	CbGeAlD
Sorafenib—RET—blood—schizophrenia	0.000564	0.00332	CbGeAlD
Sorafenib—MKNK1—midbrain—schizophrenia	0.000563	0.00332	CbGeAlD
Sorafenib—CSF1R—telencephalon—schizophrenia	0.000563	0.00331	CbGeAlD
Sorafenib—UGT1A9—endocrine gland—schizophrenia	0.000562	0.00331	CbGeAlD
Sorafenib—RET—midbrain—schizophrenia	0.000557	0.00328	CbGeAlD
Sorafenib—FLT4—endocrine gland—schizophrenia	0.000554	0.00326	CbGeAlD
Sorafenib—EPHA6—brain—schizophrenia	0.000553	0.00325	CbGeAlD
Sorafenib—EPHX2—cerebellum—schizophrenia	0.000541	0.00318	CbGeAlD
Sorafenib—STK10—gonad—schizophrenia	0.000539	0.00317	CbGeAlD
Sorafenib—FLT3—cerebellum—schizophrenia	0.000537	0.00316	CbGeAlD
Sorafenib—CYP1A2—blood plasma—schizophrenia	0.000536	0.00316	CbGeAlD
Sorafenib—PDGFRA—gonad—schizophrenia	0.000534	0.00314	CbGeAlD
Sorafenib—ZAK—brain—schizophrenia	0.000524	0.00309	CbGeAlD
Sorafenib—RALBP1—blood—schizophrenia	0.000522	0.00307	CbGeAlD
Sorafenib—CYP3A5—blood plasma—schizophrenia	0.000517	0.00304	CbGeAlD
Sorafenib—RALBP1—midbrain—schizophrenia	0.000515	0.00303	CbGeAlD
Sorafenib—CYP2B6—blood plasma—schizophrenia	0.000514	0.00303	CbGeAlD
Sorafenib—HIPK3—brain—schizophrenia	0.000513	0.00302	CbGeAlD
Sorafenib—KIT—telencephalon—schizophrenia	0.000511	0.00301	CbGeAlD
Sorafenib—CYP2C9—blood plasma—schizophrenia	0.000509	0.003	CbGeAlD
Sorafenib—MAP3K19—brain—schizophrenia	0.000503	0.00296	CbGeAlD
Sorafenib—MKNK2—endocrine gland—schizophrenia	0.000501	0.00295	CbGeAlD
Sorafenib—PDGFRB—telencephalon—schizophrenia	0.000499	0.00294	CbGeAlD
Sorafenib—FLT1—blood—schizophrenia	0.000496	0.00292	CbGeAlD
Sorafenib—MKNK1—endocrine gland—schizophrenia	0.000495	0.00291	CbGeAlD
Sorafenib—RAF1—blood—schizophrenia	0.000494	0.0029	CbGeAlD
Sorafenib—EPHB6—blood—schizophrenia	0.000491	0.00289	CbGeAlD
Sorafenib—Vismodegib—ABCB1—schizophrenia	0.00049	0.442	CrCbGaD
Sorafenib—FLT1—midbrain—schizophrenia	0.00049	0.00289	CbGeAlD
Sorafenib—RET—endocrine gland—schizophrenia	0.000489	0.00288	CbGeAlD
Sorafenib—RAF1—midbrain—schizophrenia	0.000487	0.00287	CbGeAlD
Sorafenib—EPHB6—midbrain—schizophrenia	0.000485	0.00285	CbGeAlD
Sorafenib—FGFR1—cerebellum—schizophrenia	0.000481	0.00283	CbGeAlD
Sorafenib—TIE1—brain—schizophrenia	0.000479	0.00282	CbGeAlD
Sorafenib—CSF1R—gonad—schizophrenia	0.00047	0.00277	CbGeAlD
Sorafenib—STK10—blood—schizophrenia	0.00047	0.00277	CbGeAlD
Sorafenib—MKNK2—nervous system—schizophrenia	0.000469	0.00276	CbGeAlD
Sorafenib—CYP3A7—endocrine gland—schizophrenia	0.000467	0.00275	CbGeAlD
Sorafenib—PDGFRA—blood—schizophrenia	0.000465	0.00274	CbGeAlD
Sorafenib—MKNK1—nervous system—schizophrenia	0.000463	0.00273	CbGeAlD
Sorafenib—BRAF—brain—schizophrenia	0.00046	0.00271	CbGeAlD
Sorafenib—HTR2C—forebrain—schizophrenia	0.000458	0.0027	CbGeAlD
Sorafenib—RET—nervous system—schizophrenia	0.000458	0.00269	CbGeAlD
Sorafenib—MAP3K7—cerebellum—schizophrenia	0.000456	0.00268	CbGeAlD
Sorafenib—RALBP1—endocrine gland—schizophrenia	0.000453	0.00266	CbGeAlD
Sorafenib—MKNK2—central nervous system—schizophrenia	0.000452	0.00266	CbGeAlD
Sorafenib—MKNK1—central nervous system—schizophrenia	0.000446	0.00262	CbGeAlD
Sorafenib—UGT1A1—blood—schizophrenia	0.000444	0.00261	CbGeAlD
Sorafenib—MKNK2—cerebellum—schizophrenia	0.000441	0.0026	CbGeAlD
Sorafenib—RET—central nervous system—schizophrenia	0.000441	0.00259	CbGeAlD
Sorafenib—EPHX2—brain—schizophrenia	0.000439	0.00259	CbGeAlD
Sorafenib—MKNK1—cerebellum—schizophrenia	0.000436	0.00257	CbGeAlD
Sorafenib—ABCC4—forebrain—schizophrenia	0.000432	0.00255	CbGeAlD
Sorafenib—RET—cerebellum—schizophrenia	0.000431	0.00253	CbGeAlD
Sorafenib—FLT1—endocrine gland—schizophrenia	0.000431	0.00253	CbGeAlD
Sorafenib—HTR2B—forebrain—schizophrenia	0.00043	0.00253	CbGeAlD
Sorafenib—RAF1—endocrine gland—schizophrenia	0.000428	0.00252	CbGeAlD
Sorafenib—KIT—gonad—schizophrenia	0.000427	0.00251	CbGeAlD
Sorafenib—RALBP1—nervous system—schizophrenia	0.000424	0.00249	CbGeAlD
Sorafenib—HTR2C—telencephalon—schizophrenia	0.000421	0.00248	CbGeAlD
Sorafenib—MAP2K5—blood—schizophrenia	0.00042	0.00247	CbGeAlD
Sorafenib—KDR—blood—schizophrenia	0.00042	0.00247	CbGeAlD
Sorafenib—PDGFRB—gonad—schizophrenia	0.000417	0.00245	CbGeAlD
Sorafenib—MAP2K5—midbrain—schizophrenia	0.000414	0.00244	CbGeAlD
Sorafenib—KDR—midbrain—schizophrenia	0.000414	0.00244	CbGeAlD
Sorafenib—CSF1R—blood—schizophrenia	0.00041	0.00241	CbGeAlD
Sorafenib—RALBP1—central nervous system—schizophrenia	0.000408	0.0024	CbGeAlD
Sorafenib—STK10—endocrine gland—schizophrenia	0.000408	0.0024	CbGeAlD
Sorafenib—CSF1R—midbrain—schizophrenia	0.000404	0.00238	CbGeAlD
Sorafenib—PDGFRA—endocrine gland—schizophrenia	0.000403	0.00237	CbGeAlD
Sorafenib—FLT1—nervous system—schizophrenia	0.000403	0.00237	CbGeAlD
Sorafenib—RAF1—nervous system—schizophrenia	0.000401	0.00236	CbGeAlD
Sorafenib—RALBP1—cerebellum—schizophrenia	0.000399	0.00235	CbGeAlD
Sorafenib—EPHB6—nervous system—schizophrenia	0.000398	0.00234	CbGeAlD
Sorafenib—FLT4—brain—schizophrenia	0.000396	0.00233	CbGeAlD
Sorafenib—HTR2B—telencephalon—schizophrenia	0.000396	0.00233	CbGeAlD
Sorafenib—FGFR1—brain—schizophrenia	0.000391	0.0023	CbGeAlD
Sorafenib—CYP3A4—blood plasma—schizophrenia	0.000388	0.00228	CbGeAlD
Sorafenib—FLT1—central nervous system—schizophrenia	0.000388	0.00228	CbGeAlD
Sorafenib—RAF1—central nervous system—schizophrenia	0.000386	0.00227	CbGeAlD
Sorafenib—UGT1A1—endocrine gland—schizophrenia	0.000385	0.00227	CbGeAlD
Sorafenib—EPHB6—central nervous system—schizophrenia	0.000384	0.00226	CbGeAlD
Sorafenib—CYP2D6—blood plasma—schizophrenia	0.000382	0.00225	CbGeAlD
Sorafenib—STK10—nervous system—schizophrenia	0.000381	0.00225	CbGeAlD
Sorafenib—FLT1—cerebellum—schizophrenia	0.000379	0.00223	CbGeAlD
Sorafenib—PDGFRA—nervous system—schizophrenia	0.000378	0.00222	CbGeAlD
Sorafenib—RAF1—cerebellum—schizophrenia	0.000377	0.00222	CbGeAlD
Sorafenib—EPHB6—cerebellum—schizophrenia	0.000375	0.00221	CbGeAlD
Sorafenib—KIT—blood—schizophrenia	0.000372	0.00219	CbGeAlD
Sorafenib—MAP3K7—brain—schizophrenia	0.00037	0.00218	CbGeAlD
Sorafenib—STK10—central nervous system—schizophrenia	0.000367	0.00216	CbGeAlD
Sorafenib—KIT—midbrain—schizophrenia	0.000367	0.00216	CbGeAlD
Sorafenib—MAP2K5—endocrine gland—schizophrenia	0.000364	0.00214	CbGeAlD
Sorafenib—KDR—endocrine gland—schizophrenia	0.000364	0.00214	CbGeAlD
Sorafenib—PDGFRA—central nervous system—schizophrenia	0.000364	0.00214	CbGeAlD
Sorafenib—PDGFRB—blood—schizophrenia	0.000363	0.00214	CbGeAlD
Sorafenib—STK10—cerebellum—schizophrenia	0.000359	0.00211	CbGeAlD
Sorafenib—PDGFRB—midbrain—schizophrenia	0.000359	0.00211	CbGeAlD
Sorafenib—MKNK2—brain—schizophrenia	0.000359	0.00211	CbGeAlD
Sorafenib—PDGFRA—cerebellum—schizophrenia	0.000355	0.00209	CbGeAlD
Sorafenib—CSF1R—endocrine gland—schizophrenia	0.000355	0.00209	CbGeAlD
Sorafenib—MKNK1—brain—schizophrenia	0.000354	0.00208	CbGeAlD
Sorafenib—RET—brain—schizophrenia	0.00035	0.00206	CbGeAlD
Sorafenib—KDR—nervous system—schizophrenia	0.000341	0.00201	CbGeAlD
Sorafenib—MAP2K5—nervous system—schizophrenia	0.000341	0.00201	CbGeAlD
Sorafenib—CSF1R—nervous system—schizophrenia	0.000332	0.00196	CbGeAlD
Sorafenib—MAP2K5—central nervous system—schizophrenia	0.000328	0.00193	CbGeAlD
Sorafenib—KDR—central nervous system—schizophrenia	0.000328	0.00193	CbGeAlD
Sorafenib—RALBP1—brain—schizophrenia	0.000324	0.00191	CbGeAlD
Sorafenib—KIT—endocrine gland—schizophrenia	0.000323	0.0019	CbGeAlD
Sorafenib—MAP2K5—cerebellum—schizophrenia	0.000321	0.00189	CbGeAlD
Sorafenib—KDR—cerebellum—schizophrenia	0.000321	0.00189	CbGeAlD
Sorafenib—CSF1R—central nervous system—schizophrenia	0.00032	0.00188	CbGeAlD
Sorafenib—PDGFRB—endocrine gland—schizophrenia	0.000315	0.00185	CbGeAlD
Sorafenib—CSF1R—cerebellum—schizophrenia	0.000313	0.00184	CbGeAlD
Sorafenib—FLT1—brain—schizophrenia	0.000308	0.00181	CbGeAlD
Sorafenib—RAF1—brain—schizophrenia	0.000306	0.0018	CbGeAlD
Sorafenib—EPHB6—brain—schizophrenia	0.000304	0.00179	CbGeAlD
Sorafenib—HTR2C—midbrain—schizophrenia	0.000302	0.00178	CbGeAlD
Sorafenib—KIT—nervous system—schizophrenia	0.000302	0.00178	CbGeAlD
Sorafenib—PDGFRB—nervous system—schizophrenia	0.000295	0.00174	CbGeAlD
Sorafenib—STK10—brain—schizophrenia	0.000292	0.00172	CbGeAlD
Sorafenib—KIT—central nervous system—schizophrenia	0.000291	0.00171	CbGeAlD
Sorafenib—ABCC4—blood—schizophrenia	0.000289	0.0017	CbGeAlD
Sorafenib—PDGFRA—brain—schizophrenia	0.000289	0.0017	CbGeAlD
Sorafenib—HTR2B—blood—schizophrenia	0.000288	0.00169	CbGeAlD
Sorafenib—KIT—cerebellum—schizophrenia	0.000284	0.00167	CbGeAlD
Sorafenib—PDGFRB—central nervous system—schizophrenia	0.000284	0.00167	CbGeAlD
Sorafenib—ABCG2—telencephalon—schizophrenia	0.000281	0.00165	CbGeAlD
Sorafenib—ABCC2—blood—schizophrenia	0.00028	0.00165	CbGeAlD
Sorafenib—PDGFRB—cerebellum—schizophrenia	0.000277	0.00163	CbGeAlD
Sorafenib—ABCB1—blood plasma—schizophrenia	0.000275	0.00162	CbGeAlD
Sorafenib—KDR—brain—schizophrenia	0.00026	0.00153	CbGeAlD
Sorafenib—MAP2K5—brain—schizophrenia	0.00026	0.00153	CbGeAlD
Sorafenib—CSF1R—brain—schizophrenia	0.000254	0.0015	CbGeAlD
Sorafenib—ABCC4—endocrine gland—schizophrenia	0.000251	0.00148	CbGeAlD
Sorafenib—HTR2C—nervous system—schizophrenia	0.000249	0.00146	CbGeAlD
Sorafenib—ABCC2—endocrine gland—schizophrenia	0.000243	0.00143	CbGeAlD
Sorafenib—CYP2C19—blood—schizophrenia	0.000241	0.00142	CbGeAlD
Sorafenib—HTR2C—central nervous system—schizophrenia	0.000239	0.00141	CbGeAlD
Sorafenib—ABCC4—nervous system—schizophrenia	0.000235	0.00138	CbGeAlD
Sorafenib—HTR2B—nervous system—schizophrenia	0.000234	0.00137	CbGeAlD
Sorafenib—KIT—brain—schizophrenia	0.000231	0.00136	CbGeAlD
Sorafenib—ABCC4—central nervous system—schizophrenia	0.000226	0.00133	CbGeAlD
Sorafenib—PDGFRB—brain—schizophrenia	0.000225	0.00133	CbGeAlD
Sorafenib—HTR2B—central nervous system—schizophrenia	0.000225	0.00132	CbGeAlD
Sorafenib—CYP2B6—gonad—schizophrenia	0.000216	0.00127	CbGeAlD
Sorafenib—CYP2C8—blood—schizophrenia	0.00021	0.00124	CbGeAlD
Sorafenib—CYP2D6—forebrain—schizophrenia	0.000209	0.00123	CbGeAlD
Sorafenib—CYP2C19—endocrine gland—schizophrenia	0.000209	0.00123	CbGeAlD
Sorafenib—ABCG2—blood—schizophrenia	0.000204	0.0012	CbGeAlD
Sorafenib—ABCG2—midbrain—schizophrenia	0.000202	0.00119	CbGeAlD
Sorafenib—CYP1A2—blood—schizophrenia	0.000196	0.00116	CbGeAlD
Sorafenib—CYP2D6—telencephalon—schizophrenia	0.000192	0.00113	CbGeAlD
Sorafenib—HTR2C—brain—schizophrenia	0.00019	0.00112	CbGeAlD
Sorafenib—CYP3A5—blood—schizophrenia	0.00019	0.00112	CbGeAlD
Sorafenib—CYP2B6—blood—schizophrenia	0.000188	0.00111	CbGeAlD
Sorafenib—CYP2C9—blood—schizophrenia	0.000187	0.0011	CbGeAlD
Sorafenib—CYP2C8—endocrine gland—schizophrenia	0.000182	0.00107	CbGeAlD
Sorafenib—ABCC4—brain—schizophrenia	0.000179	0.00106	CbGeAlD
Sorafenib—HTR2B—brain—schizophrenia	0.000179	0.00105	CbGeAlD
Sorafenib—CYP1A2—endocrine gland—schizophrenia	0.00017	0.001	CbGeAlD
Sorafenib—CYP3A5—endocrine gland—schizophrenia	0.000164	0.000967	CbGeAlD
Sorafenib—CYP2B6—endocrine gland—schizophrenia	0.000163	0.000961	CbGeAlD
Sorafenib—CYP2C9—endocrine gland—schizophrenia	0.000162	0.000952	CbGeAlD
Sorafenib—ABCG2—cerebellum—schizophrenia	0.000156	0.000918	CbGeAlD
Sorafenib—CYP2B6—nervous system—schizophrenia	0.000153	0.0009	CbGeAlD
Sorafenib—ABCB1—forebrain—schizophrenia	0.000151	0.000886	CbGeAlD
Sorafenib—CYP2B6—central nervous system—schizophrenia	0.000147	0.000866	CbGeAlD
Sorafenib—CYP3A4—blood—schizophrenia	0.000142	0.000837	CbGeAlD
Sorafenib—CYP2D6—blood—schizophrenia	0.00014	0.000824	CbGeAlD
Sorafenib—ABCB1—telencephalon—schizophrenia	0.000138	0.000815	CbGeAlD
Sorafenib—CYP2C8—brain—schizophrenia	0.00013	0.000767	CbGeAlD
Sorafenib—ABCG2—brain—schizophrenia	0.000127	0.000746	CbGeAlD
Sorafenib—CYP3A4—endocrine gland—schizophrenia	0.000123	0.000726	CbGeAlD
Sorafenib—CYP2D6—endocrine gland—schizophrenia	0.000121	0.000714	CbGeAlD
Sorafenib—CYP2B6—brain—schizophrenia	0.000117	0.000688	CbGeAlD
Sorafenib—ABCB1—gonad—schizophrenia	0.000116	0.00068	CbGeAlD
Sorafenib—CYP3A4—nervous system—schizophrenia	0.000115	0.00068	CbGeAlD
Sorafenib—CYP2D6—nervous system—schizophrenia	0.000114	0.000669	CbGeAlD
Sorafenib—CYP3A4—central nervous system—schizophrenia	0.000111	0.000654	CbGeAlD
Sorafenib—CYP2D6—central nervous system—schizophrenia	0.000109	0.000644	CbGeAlD
Sorafenib—CYP2D6—cerebellum—schizophrenia	0.000107	0.000629	CbGeAlD
Sorafenib—ABCB1—blood—schizophrenia	0.000101	0.000593	CbGeAlD
Sorafenib—ABCB1—midbrain—schizophrenia	9.94e-05	0.000585	CbGeAlD
Sorafenib—ABCB1—endocrine gland—schizophrenia	8.73e-05	0.000514	CbGeAlD
Sorafenib—CYP2D6—brain—schizophrenia	8.68e-05	0.000511	CbGeAlD
Sorafenib—ABCB1—nervous system—schizophrenia	8.17e-05	0.000481	CbGeAlD
Sorafenib—ABCB1—central nervous system—schizophrenia	7.87e-05	0.000463	CbGeAlD
Sorafenib—ABCB1—cerebellum—schizophrenia	7.69e-05	0.000453	CbGeAlD
Sorafenib—ABCB1—brain—schizophrenia	6.25e-05	0.000368	CbGeAlD
Sorafenib—CYP2C9—Metabolism—CACNA1C—schizophrenia	3.56e-06	1.44e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PLA2G4A—schizophrenia	3.54e-06	1.43e-05	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.52e-06	1.43e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—APOE—schizophrenia	3.52e-06	1.42e-05	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—TP53—schizophrenia	3.51e-06	1.42e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PIK3C2A—schizophrenia	3.5e-06	1.42e-05	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—AKT1—schizophrenia	3.49e-06	1.41e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—APOE—schizophrenia	3.49e-06	1.41e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—APOA1—schizophrenia	3.48e-06	1.41e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PIK3C2A—schizophrenia	3.47e-06	1.41e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NRG1—schizophrenia	3.47e-06	1.41e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CYP1A2—schizophrenia	3.46e-06	1.4e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—AKT1—schizophrenia	3.46e-06	1.4e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GAPDH—schizophrenia	3.45e-06	1.4e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—APOA1—schizophrenia	3.45e-06	1.4e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—ESR1—schizophrenia	3.44e-06	1.39e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MEF2C—schizophrenia	3.44e-06	1.39e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—COMT—schizophrenia	3.43e-06	1.39e-05	CbGpPWpGaD
Sorafenib—FGFR1—Disease—EP300—schizophrenia	3.42e-06	1.39e-05	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—AKT1—schizophrenia	3.42e-06	1.39e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—EP300—schizophrenia	3.42e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CLOCK—schizophrenia	3.42e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CYP2D6—schizophrenia	3.42e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—SNAP25—schizophrenia	3.42e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—TH—schizophrenia	3.41e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GSTP1—schizophrenia	3.41e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	3.41e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—MAOA—schizophrenia	3.4e-06	1.38e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—TPH1—schizophrenia	3.39e-06	1.37e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GCLM—schizophrenia	3.39e-06	1.37e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APOE—schizophrenia	3.37e-06	1.36e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	3.37e-06	1.36e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—COMT—schizophrenia	3.35e-06	1.36e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—EP300—schizophrenia	3.34e-06	1.35e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—EP300—schizophrenia	3.33e-06	1.35e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CYP2D6—schizophrenia	3.33e-06	1.35e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—SNAP25—schizophrenia	3.33e-06	1.35e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APOA1—schizophrenia	3.33e-06	1.35e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GSTP1—schizophrenia	3.33e-06	1.35e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—TPH2—schizophrenia	3.33e-06	1.35e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CACNB2—schizophrenia	3.33e-06	1.35e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—YWHAZ—schizophrenia	3.32e-06	1.35e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—MAOA—schizophrenia	3.32e-06	1.35e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL1B—schizophrenia	3.32e-06	1.35e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	3.32e-06	1.34e-05	CbGpPWpGaD
Sorafenib—CDK7—Disease—AKT1—schizophrenia	3.31e-06	1.34e-05	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—AKT1—schizophrenia	3.29e-06	1.33e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	3.28e-06	1.33e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—DPYD—schizophrenia	3.27e-06	1.33e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—EP300—schizophrenia	3.26e-06	1.32e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—ERBB3—schizophrenia	3.25e-06	1.32e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ABCB1—schizophrenia	3.23e-06	1.31e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—ESR1—schizophrenia	3.22e-06	1.3e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PRKD1—schizophrenia	3.19e-06	1.29e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ABCB1—schizophrenia	3.15e-06	1.28e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—SNAP25—schizophrenia	3.14e-06	1.27e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PLA2G4A—schizophrenia	3.13e-06	1.27e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GSTM1—schizophrenia	3.13e-06	1.27e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR2A—schizophrenia	3.13e-06	1.27e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—GSK3B—schizophrenia	3.12e-06	1.26e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CYP2D6—schizophrenia	3.11e-06	1.26e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—SNAP25—schizophrenia	3.11e-06	1.26e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CYP1A2—schizophrenia	3.09e-06	1.25e-05	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—AKT1—schizophrenia	3.08e-06	1.25e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—EP300—schizophrenia	3.08e-06	1.25e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PLA2G4A—schizophrenia	3.06e-06	1.24e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GSTM1—schizophrenia	3.06e-06	1.24e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CACNA1C—schizophrenia	3.04e-06	1.23e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—TH—schizophrenia	3.04e-06	1.23e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CYP1A2—schizophrenia	3.01e-06	1.22e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—EP300—schizophrenia	2.97e-06	1.2e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—TH—schizophrenia	2.97e-06	1.2e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PIK3C2A—schizophrenia	2.97e-06	1.2e-05	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—AKT1—schizophrenia	2.96e-06	1.2e-05	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—AKT1—schizophrenia	2.96e-06	1.2e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—GSK3B—schizophrenia	2.92e-06	1.18e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APOE—schizophrenia	2.91e-06	1.18e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—COMT—schizophrenia	2.9e-06	1.17e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GSTP1—schizophrenia	2.89e-06	1.17e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—MAOA—schizophrenia	2.88e-06	1.17e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APOA1—schizophrenia	2.88e-06	1.16e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CYP1A2—schizophrenia	2.84e-06	1.15e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CYP1A2—schizophrenia	2.82e-06	1.14e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—EP300—schizophrenia	2.8e-06	1.13e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—TH—schizophrenia	2.8e-06	1.13e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.79e-06	1.13e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—ESR1—schizophrenia	2.78e-06	1.12e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—EP300—schizophrenia	2.78e-06	1.12e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—TH—schizophrenia	2.78e-06	1.12e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—MTHFR—schizophrenia	2.77e-06	1.12e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—EP300—schizophrenia	2.74e-06	1.11e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ABCB1—schizophrenia	2.73e-06	1.11e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—MTHFR—schizophrenia	2.71e-06	1.1e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CYP2D6—schizophrenia	2.66e-06	1.08e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—SNAP25—schizophrenia	2.66e-06	1.08e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GAPDH—schizophrenia	2.66e-06	1.08e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PLA2G4A—schizophrenia	2.65e-06	1.07e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GSTM1—schizophrenia	2.65e-06	1.07e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CLOCK—schizophrenia	2.64e-06	1.07e-05	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—AKT1—schizophrenia	2.62e-06	1.06e-05	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—AKT1—schizophrenia	2.6e-06	1.05e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—COMT—schizophrenia	2.59e-06	1.05e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—APOE—schizophrenia	2.58e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GSTP1—schizophrenia	2.58e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—MAOA—schizophrenia	2.57e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—TPH2—schizophrenia	2.57e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CACNB2—schizophrenia	2.57e-06	1.04e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—APOA1—schizophrenia	2.55e-06	1.03e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—DPYD—schizophrenia	2.53e-06	1.02e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—EP300—schizophrenia	2.53e-06	1.02e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—EP300—schizophrenia	2.53e-06	1.02e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—COMT—schizophrenia	2.53e-06	1.02e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—GSK3B—schizophrenia	2.52e-06	1.02e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—APOE—schizophrenia	2.52e-06	1.02e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GSTP1—schizophrenia	2.51e-06	1.02e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MAOA—schizophrenia	2.51e-06	1.02e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.49e-06	1.01e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—APOA1—schizophrenia	2.49e-06	1.01e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ABCB1—schizophrenia	2.44e-06	9.87e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—EP300—schizophrenia	2.4e-06	9.71e-06	CbGpPWpGaD
Sorafenib—BRAF—Disease—AKT1—schizophrenia	2.4e-06	9.7e-06	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TP53—schizophrenia	2.39e-06	9.69e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—EP300—schizophrenia	2.39e-06	9.69e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—COMT—schizophrenia	2.38e-06	9.64e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—TH—schizophrenia	2.37e-06	9.6e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GSTP1—schizophrenia	2.37e-06	9.59e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PLA2G4A—schizophrenia	2.37e-06	9.59e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GSTM1—schizophrenia	2.37e-06	9.59e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MAOA—schizophrenia	2.36e-06	9.57e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—AKT1—schizophrenia	2.36e-06	9.57e-06	CbGpPWpGaD
Sorafenib—KIT—Immune System—AKT1—schizophrenia	2.36e-06	9.57e-06	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—EP300—schizophrenia	2.36e-06	9.56e-06	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—EP300—schizophrenia	2.36e-06	9.56e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—COMT—schizophrenia	2.36e-06	9.56e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CACNA1C—schizophrenia	2.35e-06	9.51e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GSTP1—schizophrenia	2.35e-06	9.51e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—MTHFR—schizophrenia	2.34e-06	9.49e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MAOA—schizophrenia	2.34e-06	9.49e-06	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TP53—schizophrenia	2.33e-06	9.45e-06	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—AKT1—schizophrenia	2.32e-06	9.38e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PLA2G4A—schizophrenia	2.31e-06	9.36e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GSTM1—schizophrenia	2.31e-06	9.36e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	2.29e-06	9.27e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.27e-06	9.2e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ABCB1—schizophrenia	2.24e-06	9.08e-06	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—AKT1—schizophrenia	2.24e-06	9.08e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—AKT1—schizophrenia	2.24e-06	9.05e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ABCB1—schizophrenia	2.22e-06	9e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—APOE—schizophrenia	2.18e-06	8.84e-06	CbGpPWpGaD
Sorafenib—KIT—Disease—AKT1—schizophrenia	2.18e-06	8.83e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GSTM1—schizophrenia	2.18e-06	8.82e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PLA2G4A—schizophrenia	2.18e-06	8.82e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GSTM1—schizophrenia	2.16e-06	8.74e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PLA2G4A—schizophrenia	2.16e-06	8.74e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—APOA1—schizophrenia	2.16e-06	8.73e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—EP300—schizophrenia	2.16e-06	8.73e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—AKT1—schizophrenia	2.1e-06	8.51e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—MTHFR—schizophrenia	2.09e-06	8.47e-06	CbGpPWpGaD
Sorafenib—FGFR1—Disease—AKT1—schizophrenia	2.07e-06	8.38e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—AKT1—schizophrenia	2.06e-06	8.36e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—EP300—schizophrenia	2.06e-06	8.32e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—SNAP25—schizophrenia	2.05e-06	8.32e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP2D6—schizophrenia	2.05e-06	8.32e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MTHFR—schizophrenia	2.04e-06	8.27e-06	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—AKT1—schizophrenia	2.02e-06	8.18e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—COMT—schizophrenia	2.02e-06	8.17e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—AKT1—schizophrenia	2.01e-06	8.16e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GSTP1—schizophrenia	2.01e-06	8.13e-06	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TP53—schizophrenia	2.01e-06	8.12e-06	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—EP300—schizophrenia	2e-06	8.11e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MAOA—schizophrenia	2e-06	8.11e-06	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TP53—schizophrenia	1.99e-06	8.05e-06	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—EP300—schizophrenia	1.99e-06	8.04e-06	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—AKT1—schizophrenia	1.97e-06	7.98e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—AKT1—schizophrenia	1.97e-06	7.96e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOE—schizophrenia	1.95e-06	7.89e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.94e-06	7.86e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOA1—schizophrenia	1.93e-06	7.8e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MTHFR—schizophrenia	1.92e-06	7.79e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—EP300—schizophrenia	1.92e-06	7.78e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MTHFR—schizophrenia	1.91e-06	7.72e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOE—schizophrenia	1.9e-06	7.7e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ABCB1—schizophrenia	1.9e-06	7.69e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOA1—schizophrenia	1.88e-06	7.61e-06	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—AKT1—schizophrenia	1.87e-06	7.56e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—AKT1—schizophrenia	1.86e-06	7.53e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP1A2—schizophrenia	1.86e-06	7.52e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PLA2G4A—schizophrenia	1.84e-06	7.47e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GSTM1—schizophrenia	1.84e-06	7.47e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—TH—schizophrenia	1.83e-06	7.41e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TP53—schizophrenia	1.81e-06	7.32e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TP53—schizophrenia	1.81e-06	7.32e-06	CbGpPWpGaD
Sorafenib—RAF1—Immune System—AKT1—schizophrenia	1.8e-06	7.27e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOE—schizophrenia	1.79e-06	7.25e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOE—schizophrenia	1.78e-06	7.19e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOA1—schizophrenia	1.77e-06	7.17e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOA1—schizophrenia	1.76e-06	7.11e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TP53—schizophrenia	1.72e-06	6.95e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TP53—schizophrenia	1.71e-06	6.93e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—AKT1—schizophrenia	1.7e-06	6.87e-06	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—AKT1—schizophrenia	1.69e-06	6.86e-06	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—AKT1—schizophrenia	1.68e-06	6.79e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—EP300—schizophrenia	1.66e-06	6.71e-06	CbGpPWpGaD
Sorafenib—RAF1—Disease—AKT1—schizophrenia	1.66e-06	6.71e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MTHFR—schizophrenia	1.63e-06	6.6e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—COMT—schizophrenia	1.56e-06	6.3e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GSTP1—schizophrenia	1.55e-06	6.27e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MAOA—schizophrenia	1.55e-06	6.26e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TP53—schizophrenia	1.54e-06	6.25e-06	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—AKT1—schizophrenia	1.53e-06	6.18e-06	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—AKT1—schizophrenia	1.53e-06	6.18e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOE—schizophrenia	1.52e-06	6.15e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOA1—schizophrenia	1.5e-06	6.08e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TP53—schizophrenia	1.47e-06	5.96e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—EP300—schizophrenia	1.47e-06	5.95e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ABCB1—schizophrenia	1.47e-06	5.94e-06	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—AKT1—schizophrenia	1.45e-06	5.87e-06	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—AKT1—schizophrenia	1.45e-06	5.85e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—EP300—schizophrenia	1.44e-06	5.81e-06	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—AKT1—schizophrenia	1.43e-06	5.78e-06	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—AKT1—schizophrenia	1.43e-06	5.78e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GSTM1—schizophrenia	1.42e-06	5.76e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	1.42e-06	5.76e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TP53—schizophrenia	1.37e-06	5.57e-06	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	1.3e-06	5.27e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MTHFR—schizophrenia	1.26e-06	5.09e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—EP300—schizophrenia	1.24e-06	5.04e-06	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—AKT1—schizophrenia	1.24e-06	5.03e-06	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—AKT1—schizophrenia	1.21e-06	4.9e-06	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—AKT1—schizophrenia	1.2e-06	4.86e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TP53—schizophrenia	1.19e-06	4.81e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOE—schizophrenia	1.17e-06	4.74e-06	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—AKT1—schizophrenia	1.16e-06	4.7e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOA1—schizophrenia	1.16e-06	4.69e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—EP300—schizophrenia	1.11e-06	4.49e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—EP300—schizophrenia	1.08e-06	4.39e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—EP300—schizophrenia	1.02e-06	4.13e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—EP300—schizophrenia	1.01e-06	4.1e-06	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—AKT1—schizophrenia	1e-06	4.06e-06	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—AKT1—schizophrenia	8.88e-07	3.59e-06	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—AKT1—schizophrenia	8.68e-07	3.51e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—EP300—schizophrenia	8.65e-07	3.5e-06	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—AKT1—schizophrenia	7.51e-07	3.04e-06	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—AKT1—schizophrenia	6.71e-07	2.72e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—EP300—schizophrenia	6.67e-07	2.7e-06	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—AKT1—schizophrenia	6.55e-07	2.65e-06	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—AKT1—schizophrenia	6.17e-07	2.5e-06	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—AKT1—schizophrenia	6.12e-07	2.48e-06	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—AKT1—schizophrenia	5.23e-07	2.12e-06	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—AKT1—schizophrenia	4.03e-07	1.63e-06	CbGpPWpGaD
